Navana Pharmaceuticals (DHA:NAVANAPHAR) Growth Rank : 0 (As of Dec. 13, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Navana Pharmaceuticals Growth Rank?

Navana Pharmaceuticals has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Navana Pharmaceuticals Growth Rank Related Terms

Thank you for viewing the detailed overview of Navana Pharmaceuticals's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Navana Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Navana Pharmaceuticals PLC (DHA:NAVANAPHAR) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

Road 4, House 99, Block B, Banani, Dhaka, BGD, 1213

Website

https://www.navanapharma.com

Navana Pharmaceuticals PLC operates its business under two divisions namely Veterinary Division and Human Health Division. Veterinary Division manufactures and markets high-quality veterinary medicine and feed supplements for different segments including poultry, dairy and aqua products. Human Health Division operates its manufacturing facilities in strict compliance with WHO cGMP guidelines for the production of tablets, capsules, oral liquids, ampoules, dry powder vials, powder for suspension, eye drops, creams and ointments.

Navana Pharmaceuticals Headlines

No Headlines